CellmAbs
Description: Cellmabs develops biopharmaceuticals for cancer treatment, led by experts in glycoimmunology & oncology.
Country: Portugal
Based in: Lisbon
Founded: 2019
Funding Stage: Seed
Tags: ['Biotechnology', 'glycoimmunology', 'oncology']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.












